Branded Formulations

Jump to

Biocon Q1 net up 17% at Rs 147 cr

The Bangalore-based firm had posted a net profit of Rs 126 crore during the same period of previous fiscal.
Biocon Q4 net jumps on exceptional gains; EBITDA down 21%

Biocon's fourth quarter consolidated net profit grew 2.5 times year-on-year to Rs 249 crore, boosted by one time exceptional income of Rs 202 crore.
Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr

Pharmaceutical company Biocon has reported better than expected topline as well as bottomline numbers in its fourth quarter of FY12. Its net profit fell 3% to Rs 98 crore in the January-March quarter of 2012 from Rs 101 crore in a year ago period.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Branded Formulations

Biocon Q1 net up 17% at Rs 147 cr

Biocon Q4 net jumps on exceptional gains; EBITDA down 21%

Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr